Cited 0 time in
Effectiveness of single-pill combination olmesartan/amlodipine/hydrochlorothiazide therapy in patients with apparent resistant hypertension
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Oh, Jaewon | - |
| dc.contributor.author | Kim, Wonho | - |
| dc.contributor.author | Kim, Gee-Hee | - |
| dc.contributor.author | Kim, Hack-Lyoung | - |
| dc.contributor.author | Park, Sang-Don | - |
| dc.contributor.author | Min, Kyung Wan | - |
| dc.contributor.author | Hyun, Dongkeun | - |
| dc.contributor.author | Hong, Jun Hwa | - |
| dc.contributor.author | Lim, Soo | - |
| dc.contributor.author | Bae, Ji-Hwan | - |
| dc.contributor.author | Shin, Jinho | - |
| dc.date.accessioned | 2026-05-11T00:00:08Z | - |
| dc.date.available | 2026-05-11T00:00:08Z | - |
| dc.date.issued | 2025-09 | - |
| dc.identifier.issn | 0950-9240 | - |
| dc.identifier.issn | 1476-5527 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/212606 | - |
| dc.description.abstract | This pioneering study investigated the real-life effectiveness of single-pill combination (SPC) antihypertensive therapy in patients with uncontrolled blood pressure (BP) and cardiovascular risk factors. After treatment with olmesartan medoxomil/amlodipine besylate/hydrochlorothiazide for 24 weeks, adults with apparent resistant hypertension had significantly reduced systolic BP and approximately 80% achieved target BP. SPC therapy may improve adherence in patients with pseudo-resistant hypertension and is a potentially effective treatment for resistant hypertension. | - |
| dc.format.extent | 4 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | SPRINGERNATURE | - |
| dc.title | Effectiveness of single-pill combination olmesartan/amlodipine/hydrochlorothiazide therapy in patients with apparent resistant hypertension | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1038/s41371-025-01043-3 | - |
| dc.identifier.scopusid | 2-s2.0-105015807235 | - |
| dc.identifier.wosid | 001528208900001 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF HUMAN HYPERTENSION, v.39, no.9, pp 675 - 678 | - |
| dc.citation.title | JOURNAL OF HUMAN HYPERTENSION | - |
| dc.citation.volume | 39 | - |
| dc.citation.number | 9 | - |
| dc.citation.startPage | 675 | - |
| dc.citation.endPage | 678 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
| dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
| dc.subject.keywordAuthor | Amlodipine | - |
| dc.subject.keywordAuthor | Hydrochlorothiazide | - |
| dc.subject.keywordAuthor | Olmesartan | - |
| dc.subject.keywordAuthor | Amlodipine | - |
| dc.subject.keywordAuthor | Antihypertensive Agents | - |
| dc.subject.keywordAuthor | Drug Combinations | - |
| dc.subject.keywordAuthor | Hydrochlorothiazide | - |
| dc.subject.keywordAuthor | Imidazoles | - |
| dc.subject.keywordAuthor | Olmesartan | - |
| dc.subject.keywordAuthor | Olmesartan Medoxomil | - |
| dc.subject.keywordAuthor | Tetrazoles | - |
| dc.subject.keywordAuthor | Amlodipine | - |
| dc.subject.keywordAuthor | Antihypertensive Agent | - |
| dc.subject.keywordAuthor | Hydrochlorothiazide | - |
| dc.subject.keywordAuthor | Imidazole Derivative | - |
| dc.subject.keywordAuthor | Olmesartan | - |
| dc.subject.keywordAuthor | Tetrazole Derivative | - |
| dc.subject.keywordAuthor | Adult | - |
| dc.subject.keywordAuthor | Aged | - |
| dc.subject.keywordAuthor | Blood Pressure | - |
| dc.subject.keywordAuthor | Combination Drug Therapy | - |
| dc.subject.keywordAuthor | Diagnosis | - |
| dc.subject.keywordAuthor | Drug Combination | - |
| dc.subject.keywordAuthor | Drug Effect | - |
| dc.subject.keywordAuthor | Drug Resistance | - |
| dc.subject.keywordAuthor | Drug Therapy | - |
| dc.subject.keywordAuthor | Female | - |
| dc.subject.keywordAuthor | Human | - |
| dc.subject.keywordAuthor | Hypertension | - |
| dc.subject.keywordAuthor | Male | - |
| dc.subject.keywordAuthor | Middle Aged | - |
| dc.subject.keywordAuthor | Pathophysiology | - |
| dc.subject.keywordAuthor | Treatment Outcome | - |
| dc.subject.keywordAuthor | Adult | - |
| dc.subject.keywordAuthor | Aged | - |
| dc.subject.keywordAuthor | Amlodipine | - |
| dc.subject.keywordAuthor | Antihypertensive Agents | - |
| dc.subject.keywordAuthor | Blood Pressure | - |
| dc.subject.keywordAuthor | Drug Combinations | - |
| dc.subject.keywordAuthor | Drug Resistance | - |
| dc.subject.keywordAuthor | Drug Therapy, Combination | - |
| dc.subject.keywordAuthor | Female | - |
| dc.subject.keywordAuthor | Humans | - |
| dc.subject.keywordAuthor | Hydrochlorothiazide | - |
| dc.subject.keywordAuthor | Hypertension | - |
| dc.subject.keywordAuthor | Imidazoles | - |
| dc.subject.keywordAuthor | Male | - |
| dc.subject.keywordAuthor | Middle Aged | - |
| dc.subject.keywordAuthor | Olmesartan Medoxomil | - |
| dc.subject.keywordAuthor | Tetrazoles | - |
| dc.subject.keywordAuthor | Treatment Outcome | - |
| dc.identifier.url | https://www.nature.com/articles/s41371-025-01043-3 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
